C-type CNP
Selected indexed studies
- C-type natriuretic peptide (CNP): The cardiovascular system and beyond. (Pharmacol Ther, 2024) [PMID:39154787]
- TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias. (J Pharmacol Exp Ther, 2019) [PMID:31235532]
- C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. (Curr Pharm Des, 2010) [PMID:21247399]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- C-type natriuretic peptide (CNP): The cardiovascular system and beyond. (2024) pubmed
- TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias. (2019) pubmed
- C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. (2010) pubmed
- Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. (2010) pubmed
- Effect of C-Type Natriuretic Peptide (CNP) on Spermatozoa Maturation in Adult Rat Epididymis. (2023) pubmed
- Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. (2002) pubmed
- C-Type Natriuretic Peptide (CNP) Could Improve Sperm Motility and Reproductive Function of Asthenozoospermia. (2022) pubmed
- C-type natriuretic peptide (CNP) inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/Croton oil-induced skin tumor growth by modulating inflammation in Swiss albino mice. (2023) pubmed
- C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis. (2018) pubmed
- C-type natriuretic peptide in childhood obesity. (2021) pubmed